232 related articles for article (PubMed ID: 20423350)
1. Enhancement of inflammatory mediator release by beta(2)-adrenoceptor agonists in airway epithelial cells is reversed by glucocorticoid action.
Holden NS; Rider CF; Bell MJ; Velayudhan J; King EM; Kaur M; Salmon M; Giembycz MA; Newton R
Br J Pharmacol; 2010 May; 160(2):410-20. PubMed ID: 20423350
[TBL] [Abstract][Full Text] [Related]
2. Effect of beta2-adrenoceptor agonists and other cAMP-elevating agents on inflammatory gene expression in human ASM cells: a role for protein kinase A.
Kaur M; Holden NS; Wilson SM; Sukkar MB; Chung KF; Barnes PJ; Newton R; Giembycz MA
Am J Physiol Lung Cell Mol Physiol; 2008 Sep; 295(3):L505-14. PubMed ID: 18586957
[TBL] [Abstract][Full Text] [Related]
3. Suppressive effects of formoterol and salmeterol on eotaxin-1 in bronchial epithelial cells.
Chu YT; Chang TT; Jong YJ; Kuo PL; Lee HM; Lee MS; Chang HW; Hung CH
Pediatr Allergy Immunol; 2010 Mar; 21(2 Pt 1):345-52. PubMed ID: 20003162
[TBL] [Abstract][Full Text] [Related]
4. Corticosteroids and beta2 agonists differentially regulate rhinovirus-induced interleukin-6 via distinct Cis-acting elements.
Edwards MR; Haas J; Panettieri RA; Johnson M; Johnston SL
J Biol Chem; 2007 May; 282(21):15366-75. PubMed ID: 17395587
[TBL] [Abstract][Full Text] [Related]
5. Formoterol and salmeterol induce a similar degree of β2-adrenoceptor tolerance in human small airways but via different mechanisms.
Cooper PR; Kurten RC; Zhang J; Nicholls DJ; Dainty IA; Panettieri RA
Br J Pharmacol; 2011 Jun; 163(3):521-32. PubMed ID: 21306583
[TBL] [Abstract][Full Text] [Related]
6. Long-acting beta2-adrenoceptor agonists synergistically enhance glucocorticoid-dependent transcription in human airway epithelial and smooth muscle cells.
Kaur M; Chivers JE; Giembycz MA; Newton R
Mol Pharmacol; 2008 Jan; 73(1):203-14. PubMed ID: 17901197
[TBL] [Abstract][Full Text] [Related]
7. Potentiation of NF-kappaB-dependent transcription and inflammatory mediator release by histamine in human airway epithelial cells.
Holden NS; Gong W; King EM; Kaur M; Giembycz MA; Newton R
Br J Pharmacol; 2007 Nov; 152(6):891-902. PubMed ID: 17891168
[TBL] [Abstract][Full Text] [Related]
8. Effect of formoterol and salmeterol on IL-6 and IL-8 release in airway epithelial cells.
Strandberg K; Palmberg L; Larsson K
Respir Med; 2007 Jun; 101(6):1132-9. PubMed ID: 17229563
[TBL] [Abstract][Full Text] [Related]
9. Long-acting beta 2 agonists suppress IP-10 expression in human bronchial epithelial cells.
Chien JW; Chu YT; Yang SN; Kuo CH; Wang WL; Kuo PL; Jong YJ; Hung CH
J Investig Med; 2012 Oct; 60(7):1048-53. PubMed ID: 22914602
[TBL] [Abstract][Full Text] [Related]
10. Long acting inhaled beta-adrenoceptor agonists the comparative pharmacology of formoterol and salmeterol.
Anderson GP
Agents Actions Suppl; 1993; 43():253-69. PubMed ID: 8103622
[TBL] [Abstract][Full Text] [Related]
11. Cytokine-induced loss of glucocorticoid function: effect of kinase inhibitors, long-acting β(2)-adrenoceptor [corrected] agonist and glucocorticoid receptor ligands.
Rider CF; Shah S; Miller-Larsson A; Giembycz MA; Newton R
PLoS One; 2015; 10(1):e0116773. PubMed ID: 25625944
[TBL] [Abstract][Full Text] [Related]
12. Modulation of transcriptional responses by poly(I:C) and human rhinovirus: effect of long-acting β₂-adrenoceptor agonists.
Rider CF; Miller-Larsson A; Proud D; Giembycz MA; Newton R
Eur J Pharmacol; 2013 May; 708(1-3):60-7. PubMed ID: 23523474
[TBL] [Abstract][Full Text] [Related]
13. Pharmacological basis for duration of effect: formoterol and salmeterol versus short-acting beta 2-adrenoceptor agonists.
Lindén A; Rabe KF; Löfdahl CG
Lung; 1996; 174(1):1-22. PubMed ID: 8746998
[TBL] [Abstract][Full Text] [Related]
14. In vivo effect of albuterol on methacholine-contracted bronchi in conjunction with salmeterol and formoterol.
Aziz I; Lipworth BJ
J Allergy Clin Immunol; 1999 May; 103(5 Pt 1):816-22. PubMed ID: 10329815
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of basal and stimulated release of endothelin-1 from guinea pig tracheal epithelial cells in culture by beta 2-adrenoceptor agonists and cyclic AMP enhancers.
Yang Q; Battistini B; Pelletier S; Sirois P
Inflammation; 2007 Oct; 30(5):136-47. PubMed ID: 17620004
[TBL] [Abstract][Full Text] [Related]
16. Agonist-induced β2-adrenoceptor desensitization and downregulation enhance pro-inflammatory cytokine release in human bronchial epithelial cells.
Oehme S; Mittag A; Schrödl W; Tarnok A; Nieber K; Abraham G
Pulm Pharmacol Ther; 2015 Feb; 30():110-20. PubMed ID: 24915152
[TBL] [Abstract][Full Text] [Related]
17. Long-acting beta 2-agonists.
Tattersfield AE
Clin Exp Allergy; 1992 Jun; 22(6):600-5. PubMed ID: 1356604
[No Abstract] [Full Text] [Related]
18. Transcriptome-Level Interactions between Budesonide and Formoterol Provide Insight into the Mechanism of Action of Inhaled Corticosteroid/Long-Acting
Mostafa MM; Rider CF; Wathugala ND; Leigh R; Giembycz MA; Newton R
Mol Pharmacol; 2021 Mar; 99(3):197-216. PubMed ID: 33376135
[TBL] [Abstract][Full Text] [Related]
19. Induction of regulator of G-protein signaling 2 expression by long-acting β2-adrenoceptor agonists and glucocorticoids in human airway epithelial cells.
Holden NS; George T; Rider CF; Chandrasekhar A; Shah S; Kaur M; Johnson M; Siderovski DP; Leigh R; Giembycz MA; Newton R
J Pharmacol Exp Ther; 2014 Jan; 348(1):12-24. PubMed ID: 24163441
[TBL] [Abstract][Full Text] [Related]
20. The effects of beta 2-adrenoceptor agonists and a corticosteroid, budesonide, on the secretion of inflammatory mediators from monocytes.
Linden M
Br J Pharmacol; 1992 Sep; 107(1):156-60. PubMed ID: 1358381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
